Etodolac, aspirin, and placebo in patients with degenerative joint disease: a twelve-week study (Q50594699): Preview

Etodolac, aspirin, and placebo in patients with degenerative joint disease: a twelve-week study (Q50594699)
scientific article published on January 1, 1983

Language:

Current Data About Etodolac, aspirin, and placebo in patients with degenerative joint disease: a twelve-week study

(P31)

(Q13442814)

(P248)
(P698)	6226358
(P813)	Friday, March 16, 2018
(P854)	http://europepmc.org/abstract/MED/6226358

(P304)

651-661

(P248)
(P698)	6226358
(P813)	Friday, March 16, 2018
(P854)	http://europepmc.org/abstract/MED/6226358

(P407)

(Q1860)

(P248)
(P698)	6226358
(P854)	https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6226358
(P813)	Friday, September 1, 2023

(P433)

(P248)
(P698)	6226358
(P813)	Friday, March 16, 2018
(P854)	http://europepmc.org/abstract/MED/6226358

(P478)

(P248)
(P698)	6226358
(P813)	Friday, March 16, 2018
(P854)	http://europepmc.org/abstract/MED/6226358

(P577)

Saturday, January 1, 1983

(P248)
(P698)	6226358
(P813)	Friday, March 16, 2018
(P854)	http://europepmc.org/abstract/MED/6226358

(P921)

(Q269829)

(P887)

(Q18216)

(P887)

(P1433)

(Q15716601)

(P248)
(P698)	6226358
(P813)	Friday, March 16, 2018
(P854)	http://europepmc.org/abstract/MED/6226358

(P1476)

"Etodolac, aspirin, and placebo in patients with degenerative joint disease: a twelve-week study" (language: en)

(P248)
(P698)	6226358
(P854)	https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6226358
(P813)	Friday, September 1, 2023

(P2093)

S. Y. Andelman

(P1545)	1

(P248)
(P698)	6226358
(P854)	https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6226358
(P813)	Friday, September 1, 2023

other details

description	scientific article published on January 1, 1983

External Links

(P698)	6226358